Notably, 19 CLL patients with relapsed/refractory disease received autologous T cells transduced to express a CAR comprising CD3ζ, 4-1BB and humanized anti-CD19 scFv instead of the commonly used murine one [128]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.